Company intelligence / Profile preview

OraHealth

Bellevue, Washington, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

OraHealth has commercial, OTC oral-adhering disc products (not prescription drugs) for dry mouth, mouth sores, and related oral conditions, marketed mainly under the OraCoat brand, led by its flagship XyliMelts product, with multiple patents protecting the platform through at least 2033.[2][3]

Therapeutic areas: Infectious DiseasesDermatologyOtherGastroenterology
Modalities: DeviceNon-pharmacological therapyHydrogel-based drug delivery therapy
Industry: Consumable Medical Devices

Partnerships

Quest Products (strategic merger and growth partner)[3]Promus Equity Partners (private equity sponsor of Quest)[3]Avante Mezzanine Partners (mezzanine debt and equity participant in the merger transaction)[3]MB Financial (senior credit facility provider in the merger transaction)[3]

Beyond the preview

Go deeper on OraHealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OraHealth.

Explore the full profile